The dopamine and endocannabinoid neurotransmitter systems have been implicated in delay discounting, a measure of impulsive choice, and obesity. The current study was designed to determine the extent to which haloperidol and rimonabant affected delay discounting in rats fed standard-chow and high-fat diets. Sprague-Dawley rats were allowed to free-feed under a high-fat diet (4.73 kcal/g) or a standard-chow diet (3.0 kcal/g) for 3 months. Then, operant sessions began in which rats (n = 9 standard chow; n = 10 high-fat) chose between one sucrose pellet delivered immediately versus three sucrose pellets after a series of delays. In another condition, carrot-flavored pellets replaced sucrose pellets. After behavior stabilized, acute injections of rimonabant (0.3-10 mg/kg) and haloperidol (0.003-0.1 mg/kg) were administered intraperitoneally before some choice sessions under both pellet conditions. Haloperidol and rimonabant increased discounting in both groups of rats by decreasing percent choice for the larger reinforcer and areaunder-the-curve values. Rats in the high-fat diet condition showed increased sensitivity to haloperidol compared with chow-fed controls; haloperidol increased discounting in both dietary groups in the sucrose condition, but only in the high-fatfed rats in the carrot-pellet condition. These findings indicate that blocking dopamine-2 and cannabinoid-1 receptors results in increased delay discounting, and that a high-fat diet may alter sensitivity to dopaminergic compounds using the delaydiscounting task. Behavioural Pharmacology 25:705-716
Introduction
Delay discounting, which describes a decrease in preference for a reinforcer as the delay to its receipt increases, has been implicated as a behavioral mechanism of obesity. Obese humans discount delayed reinforcers, such as money (Weller et al., 2008; Appelhans et al., 2011 Appelhans et al., , 2012 Fields et al., 2011; Best et al., 2012) and food-related stimuli (Rasmussen et al., 2010; Hendrickson and Rasmussen, 2013) , to a greater extent than healthyweight controls. These findings have also been shown in nonhumans, where obese rats choose smaller-sooner food reinforcers more often than lean controls (Boomhower et al., 2013) .
One explanation for these differences in discounting patterns for food may be alterations (either separately or concomitantly) in the dopamine and endocannabinoid neurotransmitter systems, such as those that result from exposure to high-fat diets. For example, rodents fed a high-fat diet initially have increased levels of dopamine-2 (D2) receptors in the nucleus accumbens compared to controls (South and Huang, 2008) , after which D2-receptor levels decrease as diet exposure lengthens (i.e. after 10-20 weeks) (Huang et al., 2006; Johnson and Kenny, 2010) . Dopamine signaling is closely involved with endocannabinoid activity (see reviews by Fitzgerald et al., 2012 and El Khoury et al., 2012) and extended exposure to high-fat diets also reduces the number of cannabinoid-1 (CB1) receptors in the rat nucleus accumbens compared with chow-fed controls (Harrold et al., 2002) . Indeed, high-fat diet exposure results in increased sensitivity to both D2 and CB1 agonists (see Baladi et al., 2012) and may alter the reinforcing properties of food when exposure occurs early in life (La Fleur et al., 2007; Teegarden et al., 2010) . However, no research to date has examined the contribution of D2-specific and CB1-specific blockade toward delay discounting in rats exposed to a high-fat diet. The dopamine neurotransmitter system is heavily involved in a variety of behavioral mechanisms related to food procurement (see Salamone et al., 2009) , including delay discounting. Dopamine agonists, for example, typically decrease delay discounting by increasing preference for larger, delayed reinforcers (Wade et al., 2000; De Wit et al., 2002; Huskinson et al., 2012; Krebs and Anderson, 2012) and nonselective D2/D3 antagonists (i.e. flupenthixol and raclopride) increase discounting (Wade et al., 2000) . Although haloperidol (a nonselective D2 antagonist) increased choice for smaller, immediate food reinforcers in a study using a T-maze (Denk et al., 2005) , other studies have found that haloperidol does not affect delay discounting (e.g. Evenden and Ryan, 1996) . These discrepant findings may result from procedural variables, such as floor effects in responding, that could mask drug effects. For example, under some delay conditions used by Evenden and Ryan (1996) , choices for the larger-later reinforcer under vehicle were 20% on average, which may have prevented haloperidol from reducing largerlater reinforcer choice (i.e. increasing discounting) further.
Recently, researchers have begun examining the role of cannabinoids in delay discounting (McDonald et al., 2003; Pattij et al., 2007; Wiskerke et al., 2011; Navarrete et al., 2012; Boomhower et al., 2013) , although the results are complex. For example, Boomhower et al. (2013) found that rimonabant (a selective CB1 antagonist and inverse agonist) increased delay discounting in lean Zucker rats and decreased discounting in obese Zuckers, strains that differ in densities of CB1 receptors (Thanos et al., 2008a (Thanos et al., , 2008b . However, other studies reported that CB1 antagonists (i.e. rimonabant and O-2050) increased discounting for food only when they were coadministered with amphetamine (Wiskerke et al., 2011) . The mechanism through which rimonabant and other CB1 antagonists may alter discounting is unclear as the potential for dopaminergic compounds to alter the behavioral effects of endocannabinoids has not been fully established. Thus, more research is needed to clarify the role of cannabinoids in delay discounting.
Although D2 and CB1 activity is involved in delay discounting for food, the degree to which a high-fat diet may alter D2-related and CB1-related changes in discounting has not been explored. The current study examined the extent to which haloperidol and rimonabant affected delay discounting in rats fed standard-chow and high-fat diets. Because high-fat diet exposure alters sensitivity to dopamine and cannabinoid agonists (Wiley et al., 2011; Baladi et al., 2012) , we expected haloperidol and rimonabant to increase discounting in rats with a history of high-fat diet exposure to a greater extent than chow-fed controls. We used a procedure that systematically presented choices between a small, immediate food reinforcer and a larger food reinforcer delivered after a series of delays. The delays were individualized for each rat, limiting floor effects that may have been present in other studies. In addition, the effects of pellet type were examined. Some reports have indicated that the effectiveness of D2-receptor and CB1-receptor blockers in decreasing food consumption may be increased when food is palatable (i.e. high in sugar or fat content) (Droste et al., 2010; Pritchett and Hajnal, 2011) , although no research has examined whether this translates into a delay discounting effect. Therefore, the effects of haloperidol and rimonabant on delay discounting were examined using both sucrose and carrot-flavored pellets, which differ in their sucrose concentration and reinforcing efficacy (e.g. Buckley and Rasmussen, 2012) .
Methods

Subjects and diets
Forty male Sprague-Dawley rats were obtained (Simonsen Laboratories, Gilroy, California, USA) at 3 weeks of age and housed in individual, clear plexiglass cages with free access to water. Subjects were housed in a temperature-controlled and humidity-controlled room and maintained on a 12 h light : dark schedule (lights on at 07:00 h). Upon arrival, rats were allowed free access to either of two diets (TestDiet, Richmond, Indiana, USA) for 3 months: a high-fat diet (n = 20; 4.73 kcal/g, 45% from fat) or a standard-chow diet (n = 20; 3.0 kcal/g, 17% from fat). These diets and exposure duration were chosen because similar methods have resulted in significant alterations in D2-receptor and CB1-receptor expression in rodents (see Harrold et al., 2002; Huang et al., 2006) . After 3 months of feeding on their respective diets, the 10 rats with the highest body mass (g) from the high-fat diet group and the 10 rats with the lowest body mass (g) from the standardchow diet group were selected for experimental sessions. Selection by body mass was made on the basis of the last 2 days' weights. One rat in the standard-chow group died because of reasons unrelated to the experiment before the sessions began. The 19 remaining rats were then maintained at 85% of their free-feeding weights to establish food as a reinforcer for the experiment. During this time, rats continued to receive their assigned diet directly after the experimental sessions, but only enough to maintain their weights at 85% of their free-feeding weight. Therefore, the rats were continuously exposed to their assigned diets throughout the experiment. All procedures were approved by the Idaho State University Institutional Animal Care and Use Committee.
Apparatus
Seven Coulbourn Habitest (Coulbourn Instruments, Whitehall, Pennsylvania, USA) rat operant chambers were used for data collection. Chambers were equipped with two levers on the right sidewall panel and were 5 cm above a grid floor with a food alcove centered between the levers. When response requirements were met, and depending on the experimental condition, one or more 45-mg sucrose pellets (95% sucrose, 3.4 kcal/g; TestDiet) or carrot-flavored pellets (3% sucrose, 3.3 kcal/g; TestDiet) were delivered to the alcove. These pellet types were chosen because these same carrot-flavored pellets were preferred less than sucrose pellets in Sprague-Dawley rats and Zucker rats in a previous study (see Buckley and Rasmussen, 2012) . Two 28-V stimulus lights were situated above each lever as well as a 28-V houselight that was 28 cm above the alcove. A 5 cm × 5 cm fan circulated air in the upper left corner of the left sidewall panel and white noise was generated from a speaker in the upper right corner of the left sidewall panel. Each chamber was placed in a sound-attenuating cubicle and Graphic State Software (Coulbourn Instruments) on a Windows-based computer (located in an adjacent room) controlled all data collection within a 0.01-s resolution.
Procedure
Delay-discounting procedure Rats were trained to press two levers in a manner similar to that described in Boomhower et al. (2013) . After training, a two-lever choice procedure was implemented based on Huskinson et al. (2012) , who report a modified version of the procedure used by Evenden and Ryan (1996) . In this procedure, a response on one lever resulted in the immediate delivery of a single pellet and a response on the opposite lever resulted in the delivery of three pellets after a series of delays that was individualized for each rat (see below). The lever that resulted in three pellets remained constant for a rat throughout the study, and whether the left or the right lever resulted in three pellets was counterbalanced across subjects. After the delivery of a reinforcer, an intertrial interval (ITI) was initiated such that each trial lasted 60 s, irrespective of which lever was chosen.
An experimental session consisted of five blocks of trials, where each block comprised two forced-choice trials, followed by 10 free-choice trials. At the start of a forcedchoice trial, the stimulus light above a randomly selected lever was illuminated. For example, if the three-pellet lever was selected by the program, a single response on this lever resulted in three pellets delivered after a delay. The stimulus light flashed (0.5 s on, 0.5 s off) above the lever until the delivery of the three pellets, which was then coupled with three 0.5-s flashes of the houselight. All lights were then extinguished for the duration of the ITI. The second forced-choice trial followed in a manner similar to the first, except that the stimulus light above the opposite lever was illuminated and a single response on this lever resulted in the delivery of one pellet immediately accompanied by a single flash of the houselight. Free-choice trials were identical to forced-choice trials in every manner, except that both stimulus lights above the levers were illuminated at the start of a trial. A response on either lever extinguished the stimulus light above the opposite lever (which became inactive for the rest of the trial) and resulted in the programmed delivery of (a) pellet(s) immediately or after a delay. If a response was not emitted before 30 s had elapsed the trial was considered omitted, all lights were extinguished, and a 60-s ITI began, after which the next free-choice trial began. Omissions were not programmed in forced-choice trials. A session ended after 2 h or the completion of five blocks (10 forced-choice and 50 free-choice trials), whichever came first. Sessions were conducted between 09:00 and 17:00 h Monday through Friday at the same time every day ( 15 min), and the number of high-fat diet and standard-chow rats in each session was counterbalanced across group and time of day at which they were run.
The delay to the three pellets was 0 s in the first block of trials and increased in each subsequent block, whereas the delay to the one pellet remained constant (0 s). Subjects were first exposed to 0-s probe sessions, where both reinforcers were delivered immediately for each block. This continued for three sessions and until the larger reinforcer choice was at least 90% (9 of 10 freechoice trials). After this criterion was fulfilled, the first delay series was implemented: 0, 1, 2, 4, and 8 s delays. In this series, the delay to the larger reinforcer was 0 s in the first block, 1 s in the second, 2 s in the third, 4 s in the fourth, and 8 s in the last block. The delay was increased in this manner for each subject until larger reinforcer choice decreased to less than 50% in at least one block after behavior stabilized (criteria described below). If larger reinforcer choice was 50% or above in all blocks after behavior stabilized under this delay series, then a 0-, 2-, 4-, 8-, and 16-s delay series was implemented. If larger reinforcer choice still remained above 50% in all blocks, a 0-, 5-, 10-, 20-, and 40-s delay series was implemented. Whether the delay series was ascending (0, 1, 2, 4, and 8 s) or descending (8, 4, 2, 1, and 0 s) across the session was counterbalanced across subjects and held constant for a rat throughout the study. All rats were exposed to two pellet conditions in which both the immediate and the delayed reinforcers were either sucrose pellets or carrot-flavored pellets. The order of these pellet conditions was counterbalanced across subjects and determination of a terminal delay series for a subject was evaluated separately for both the sucrose-pellet and carrot-pellet conditions.
Stability criteria and acute drug administration
When a delay series was implemented, baseline (noninjection) sessions were conducted for a minimum of five sessions. To ensure sensitivity to the variations in the amount and delay of reinforcement, 0-s probe sessions, in which delays to both outcomes were 0 s, were conducted every Wednesday. If larger reinforcer choice was less than 90% in any block, subsequent 0-s probe sessions were conducted until larger reinforcer choice was at least 90% in each block. We considered behavior as stable when the four criteria used by Huskinson et al. (2012) and Krebs and Anderson (2012) were fulfilled. First, the total number of larger reinforcer choices across a session could not vary by more than 20% of the grand mean of the last five sessions. Second, choice in the 0-s delay block had to be at least 90% for the last five sessions. Third, the previous 0-s probe session had to be passed within one session. Fourth, there were no three consecutive sessions during the last five sessions in which total larger reinforcer choice increased or decreased.
After behavior under baseline met the four stability criteria (above), acute drug administrations commenced. Haloperidol (0.003-0.1 mg/kg intraperitoneally) or vehicle was administered 30 min before some experimental sessions, and rimonabant (0.3-10 mg/kg intraperitoneally) or vehicle was administered 1 h before some experimental sessions. However, injections were administered only when the previous 0-s probe session was passed within one session and when larger reinforcer choice in the 0-s delay block in the previous session was at least 90%. For rimonabant, doses were injected on Tuesdays and Fridays, and for haloperidol, injections were administered on Fridays. Vehicle injections were administered on Thursdays, and all other days served as noninjection control days. Whether rimonabant or haloperidol was injected first was counterbalanced across subjects, and at least a 7-day washout period separated dose-response determinations of rimonabant and haloperidol. The injection order of the low and moderate doses of rimonabant (1-3 mg/kg) and haloperidol (0.01-0.03 mg/kg) was randomized across subjects and the highest dose of drug was injected last to minimize the chance of overdose. If fewer than five trials were completed in any block following an injection of the highest dose of haloperidol (0.1 mg/kg) or rimonabant (10 mg/kg), a smaller drug dose was administered (0.003 mg/kg haloperidol or 0.3 mg/kg rimonabant). In this way, all rats received at least three injections of drug and a vehicle injection.
Drugs
Haloperidol (Sigma-Aldrich, USA) was dissolved in a 1 : 1 : 18 solution of 3% lactic acid, a buffering agent, and saline (1 ml/kg volume). Rimonabant (National Institute of Mental Health Chemical Synthesis and Drug Supply Program) was dissolved in a 1 : 1 : 18 solution of ethanol (Sigma-Aldrich), Cremaphor (Sigma-Aldrich), and saline (1 ml/kg). These dose ranges of haloperidol and rimonabant were selected because they are behaviorally effective and are well below the toxic range.
Data analysis
Percent choice for the larger reinforcer was analyzed using a repeated-measures analysis of variance (ANOVA) (PASW Statistics 18.0, IBM, Armonk, New York, USA) with diet condition (high-fat vs. standard-chow) as a between-subjects variable, delay block as a withinsubjects variable, and dose of either rimonabant (1-10 mg/kg) or haloperidol (0.01-0.1 mg/kg) as a withinsubjects variable. A repeated-measures ANOVA was used separately to determine effects of pellet condition (sucrose vs. carrot) as a within-subjects variable. Area-under-thecurve (AUC) values (Myerson et al., 2001) were calculated by plotting percent choice for the larger reinforcer as a function of delay series (0-8, 0-16, or 0-40 s) for each subject, summing the area of the trapezoids that were formed from this curve, and dividing by the total area possible to normalize data. Thus, the AUC values ranged from 0 to 1, where lower AUC values indicated steeper discounting functions. A repeated-measures ANOVA with diet condition as a between-subjects variable and drug dose as a within-subjects variable was performed on AUC data, which were transformed into percent of vehicle values to determine drug effects.
A point about analyses of drug effects should be noted. Table 1 shows the delay series and dose range of haloperidol and rimonabant for each rat. Across the study, there were nine rats in which increased sensitivitydefined as completing fewer than five trials in a delay blockwas shown to the highest doses of haloperidol or rimonabant. These rats were administered lower doses (0.003 mg/kg haloperidol or 0.3 mg/kg rimonabant). Across the carrot-pellet condition, one standard-chow and one high-fat diet rat met this criterion under haloperidol. However, across the sucrose-pellet condition, two and four high-fat diet rats (six total) fulfilled this criterion for rimonabant and haloperidol, respectively, compared with one standard-chow rat, which was administered a smaller dose of haloperidol. We report this for two reasons. First, a greater number of rats in the high-fat diet condition requiring smaller doses may indicate differential sensitivity to the drugs as a function of diet exposure. Second, we performed repeated-measures ANOVAs that excluded these rats because they did not complete sufficient trials to warrant a meaningful analysis. However, to ensure adequate power, we also performed separate repeated-measures ANOVAs with vehicle, 'low', 'moderate', and 'high' as levels of drug dose. Because the results from these analyses were similar, we report the results from the original repeated-measures ANOVAs, which excluded subjects administered lower doses of haloperidol and rimonabant. We included these subjects' data in the means for 0.01-0.03 mg/kg haloperidol and 1-3 mg/kg rimonabant in the figures, however, as the means did not change markedly with their removal. Figure 1 shows body weight (g) of the rats in the standard-chow (n = 9) and high-fat (n = 10) diet conditions during the 3-month diet exposure. For the rats selected for experimental sessions, the ten high-fat diet rats had significantly higher body weights (M = 449.02 g, SEM = 7.64) compared with the nine standard-chow rats [M = 371.61 g, SEM = 4.01; t(17) = 8.68, P < 0.001] by the end of the diet-exposure period.
Results
Body mass
Baseline delay discounting
All data are presented as if the delay series were ascending for all subjects, given that there were no effects of delay order on larger reinforcer choice. Figure 2a shows the mean percent choice for the larger reinforcer as a function of delay in both the delay and the 0-s probe sessions for standard-chow and high-fat diet rats. Data from the carrot-pellet and sucrosepellet conditions are shown, and delays are presented as a function of the lowest non-zero delay in a delay series (see Table 1 for which delay series each rat received and whether it was ascending, e.g. 0-8, or descending, e.g. 8-0). In both the carrot and the sucrose conditions, there was a significant main effect of delay block [carrot: F(4,68) = 124.82, P < 0.001, η P 2 = 0.88; sucrose: F(4,68) = 136.33, P < 0.001, η P 2 = 0.89], indicating that as the delay to the larger reinforcer increased, larger reinforcer choice decreased. There were no main effects or interactions involving diet or pellet condition. Figure 2b shows the mean AUC for standard-chow and high-fat diet rats in the carrot-pellet and sucrose-pellet conditions. There were no significant main effects or interaction involving pellet or diet condition, indicating that the delay series implemented for each rat was functionally equivalent in reducing larger reinforcer choice.
Drug effects on delay discounting Percent choice for the larger reinforce
Because of increased trial omissions following haloperidol and rimonabant, some rats were excluded from drug analyses (shown in Table 1 ). Figure 3 shows the mean percent choice for the larger reinforcer as a function of its delay for rats administered standard-chow (top panels) and a high-fat diet (bottom panels) and varying doses of haloperidol. Data from the carrot-pellet (left panels) and sucrose-pellet (right panels) conditions are shown. The vehicle curves (bolded) represent data from sessions in which a vehicle injection was administered beforehand. Vehicle injections occurred once for each pellet condition and each drug, resulting in four different vehicle curves for one rat. In the carrot condition, there was a significant main effect of delay block [F(4,60) = 57.69, P < 0.001, η P 2 = 0.79] as the percent choice for the larger reinforcer decreased as delay increased. Haloperidol caused a dosedependent leftward shift in the discounting function [F(3,45) = 5.59, P < 0.01, η P 2 = 0.27] by reducing percent choice for the larger reinforcer. There was also a significant delay block × dose interaction [F(12,180) = 3.61, P < 0.001, η P 2 = 0.19], as haloperidol decreased percent choice for the larger reinforcer when it was delayed, but did not affect larger reinforcer percent choice in the 0-s delay block. In the sucrose condition, there were similarly significant main effects of delay block [F(4,48) = 47.78, P < 0.001, η P 2 = 0.80] and haloperidol [F(3,36) = 9.35, P < 0.001, η P 2 = 0.44], and a significant delay block × dose interaction [F(12,144) = 2.32, P = 0.01, η P 2 = 0.16]. There were no significant main effects or interactions involving diet condition or pellet type. Figure 4 shows the mean percent choice for the larger reinforcer as a function of dose of rimonabant. In the carrot condition, there was a significant main effect of delay block [F(4,68) = 77.86, P < 0.001, η P 2 = 0.82], in Week Mean SEM body weight of rats allowed free access to chow (n = 9) and high-fat (n = 10) diets for 3 months.
Haloperidol and rimonabant increase delay discounting Boomhower and Rasmussen 709 that percent choice for the larger reinforcer was reduced as the delay increased. Rimonabant also dosedependently shifted the discounting function to the left [F(3,51) = 6.94, P = 0.001, η P 2 = 0.29]. There were no significant interactions. In the sucrose condition, there were similarly significant main effects of delay block [F(4,60) = 59.86, P < 0.001, η P 2 = 0.80] and dose [F(3,45) = 4.86, P < 0.01, η P 2 = 0.25]. There was also a significant interaction [F(12,180) = 3.10, P = 0.001, η P 2 = 0.17] as rimonabant decreased percent choice for the larger reinforcer when it was delayed, but did not affect larger reinforcer percent choice in the 0-s delay block. There were no main effects or interactions involving diet condition or pellet type. Area under the curve Figure 5 shows the mean AUC values expressed as the percent of vehicle values as a function of the dose of haloperidol (a) and rimonabant (b) in standard-chow and high-fat diet rats. Data from the carrot and sucrose condition are on the left and right, respectively. In the carrotpellet condition, there were significant main effects of dose of haloperidol [F(3,45) = 6.90, P = 0.001, η P 2 = 0.32] and rimonabant [F(3,51) = 6.45, P = 0.001, η P 2 = 0.28] in that both haloperidol and rimonabant reduced AUC. At the 0.1 mg/kg dose of haloperidol, high-fat diet rats showed significantly lower AUC values than the standard-chow rats [t(15) = 2.30 P < 0.05]. In the sucrosepellet condition, there were also significant main effects Effects of haloperidol on mean SEM percent choice for the larger reinforcer as a function of its delay for rats exposed to standard-chow (upper panels) and high-fat diets (lower panels). Data from the carrot-pellet and sucrose-pellet conditions are on the left and right, respectively. HAL, haloperidol.
Haloperidol and rimonabant increase delay discounting Boomhower and Rasmussen 711 of dose of haloperidol [F(3,36) = 8.51, P < 0.001, η P 2 = 0.42] and rimonabant [F(3,45) = 5.09, P < 0.01, η P 2 = 0.25]. There were no significant main effects or interactions involving diet condition or pellet type.
Discussion
The procedure used in the current study showed that haloperidol and rimonabant increased delay discounting in rats fed high-fat and standard-chow diets. Specifically, both haloperidol and rimonabant decreased the percentage of choices allocated to larger-later reinforcers and decreased AUC values in both groups of rats. These effects were also replicated across two foods that differed in sucrose concentration and reinforcing efficacy (Buckley and Rasmussen, 2012) what some may describe as palatability. With respect to haloperidol, this study replicates and extends previous research showing that nonselective D2 antagonists decrease choice for larger, delayed reinforcers in rats (Cardinal et al., 2000; Wade et al., 2000; Denk et al., 2005) . As for rimonabant, x Effects of rimonabant on mean SEM percent choice for the larger reinforcer as a function of its delay for rats exposed to standard-chow (upper panels) and high-fat (lower panels) diets. Data from the carrot-pellet and sucrose-pellet conditions are on the left and right, respectively. RIM, rimonabant. previous studies have reported that rimonabant increases discounting in lean Zucker rats, but decreases discounting in obese Zuckers (Boomhower et al., 2013) . However, it should be noted that Boomhower et al. (2013) observed these effects in Zucker ratsa strain that differs from Sprague-Dawley rats in leptin, endocannabinoid, and dopamine signaling (DiMarzo et al., 2001; Thanos et al., 2008a Thanos et al., , 2008b )using an adjusting-delay procedure, factors that may explain why the current study found that rimonabant increased discounting in both dietary groups, rather than just the rats fed standard chow. Further, the current study also extends the literature on dopamine and endocannabinoid involvement in delay discounting by using rats with a history of consuming high-fat food.
To our knowledge, this study is the first to show that haloperidol and rimonabant increase discounting in rats fed high-fat and standard-chow diets.
A pattern of choosing smaller-sooner reinforcers can result from (a) an increased sensitivity to (or aversion toward) the delay to the larger reinforcer or (b) a decreased sensitivity to the amount of the larger reinforcer. Indeed, an advantage of the procedure used in the current study is that it parsed a measure of delay sensitivity from amount sensitivity by testing larger reinforcer choice when both reinforcers were delivered immediately (i.e. in the 0-s delay block). Neither haloperidol nor rimonabant significantly affected larger reinforcer choice in the 0-s delay block as larger reinforcer choice in the 0-s delay block remained at or above 90% on average. Therefore, haloperidol-induced and rimonabant-induced increases in discounting were not the result of changes in the amount of sensitivity, but rather the result of an increased sensitivity to the delays to reinforcement. Some research has shown that the effects on delay discounting of dopaminergic drugs, such as amphetamine, depend on conditioned stimuli during the delay (e.g. a flashing light) (Cardinal et al., 2000; Slezak and Anderson, 2009 ). Although we did not explicitly test whether the effects of haloperidol (or rimonabant) on discounting changed across differing stimulus conditions, it is possible that haloperidol and rimonabant were affecting sensitivity to conditioned reinforcers. Future research should consider manipulating the stimuli present during the delays to the larger reinforcer to answer this question.
On the basis of our statistical analyses, rats exposed to a high-fat diet showed no differences in sensitivity to rimonabant and slightly increased sensitivity to haloperidol compared with controls. Examination of Fig. 3 shows that the highest dose of haloperidol decreased choices for larger, delayed food for both pellet types to a greater extent in rats fed a high-fat diet compared with standard chow. In the upper left of Fig. 5 , this difference between groups is also reflected in the AUC values in the carrotpellet condition, although not with sucrose pellets. However, Table 1 shows that in the sucrose condition, four (40%) rats in the high-fat diet condition were so sensitive to the 0.1 mg/kg dose of haloperidol that they omitted trials to the point where their data were excluded from analysis; only one standard chow rat (11%) fulfilled this same criterion. To make an argument for increased sensitivity to haloperidol, we would expect to observe group differences at this highest dose across all measures and pellet types. However, these data cannot be disregarded, and may be interpreted at least as partial support for dopaminergic alterations induced by a high-fat diet. This would be consistent with other studies that have shown that rodents fed a high-fat diet for an extended duration show decreased D2 binding (Huang et al., 2006; Johnson and Kenny, 2010) in the brain and increased sensitivity to D2 agonists (Baladi et al., 2012) .
Differences in baseline delay discounting were not observed between diet conditions. Baseline differences might be expected as high-fat diets affected D2-receptor and CB1-receptor densities in rodents' brains in other studies (Harrold et al., 2002; Huang et al., 2006; South and Huang, 2008; Johnson and Kenny, 2010) . Although it is unclear why differences in behavior were not observed, it should be pointed out that although rats received their assigned diet throughout the study, the free-feeding condition was in place only until operant sessions commenced. At that point, rats were only administered enough of their assigned diets to maintain 85% of their free-feeding body mass. This food restriction may have reduced the potential for differences in brain neurochemistry (i.e. those specific to dopamine and cannabinoid regulation) between the dietary groups, although some research indicates that mild food restriction from standard chow and diets high in fat may increase sensitivity to D2 agonists (see Baladi et al., 2012) . Moreover, there is some evidence that mild food restriction may affect discounting in rats, but this is more so with females (e.g. Koot et al., 2009) . Future research should consider examining the potential influence of food restriction on behavioral differences between animals with exposure to high-fat and standard chow.
The current study also examined the extent to which haloperidol and rimonabant affected delay discounting when qualitatively different reinforcers (i.e. carrot vs. sucrose) were used. Previous studies have shown that haloperidol (e.g. Pritchett and Hajnal, 2011) and rimonabant (Carai et al., 2006; Droste et al., 2010;  but also see Buckley and Rasmussen, 2014) are more effective in reducing the consumption of palatable food compared with less palatable food. In the current study, haloperidol increased discounting in both high-fat-fed and standardchow-fed rats when sucrose was delivered, but only increased discounting in high-fat-fed rats when carrot pellets were delivered (Fig. 5 ). In terms of trial completions, more rats showed increased sensitivity to haloperidol (four high-fat diet and one standard chow) when sucrose pellets were delivered compared with carrot pellets (one high-fat diet and one standard chow). It could be the case that the behavioral effects of haloperidol are increased when sucrose is delivered, but a history of consuming a high-fat diet increases sensitivity to D2 antagonists regardless of reinforcer palatability.
There could be some additional interpretations of the present results. First, the increases in delay discounting observed after injections of haloperidol and rimonabant may have been the result of aging or maturation throughout the experiment. For example, some research has shown that older rats choose smaller-sooner food reinforcers more often than younger rats (e.g. Simon et al., 2010) , and these changes may be related to downregulation of D2 receptors and upregulation of CB1 receptors that occur in the striatum of aging rats (Thanos et al., 2008a (Thanos et al., , 2008b . However, we find this unlikely for two reasons: (a) we did not observe any time-dependent increases in delay discounting across the study and (b) the order of haloperidol and rimonabant was counterbalanced across subjects and therefore would distribute any drug effects related to age across groups equally. Second, the weights of the two groups of rats used in the current study differed on average by about 100 g, which may have influenced the pharmacokinetics of haloperidol and rimonabant. However, past research has shown that increased sensitivity to dopaminergic compounds after high-fat diet exposure is most likely because of changes in dopamine functioning rather than alterations in pharmacokinetics attributable to weight differences (Bowman et al., 1999; Baladi et al., 2010 Baladi et al., , 2012 . Finally, the effects of haloperidol and rimonabant on delay discounting observed in the current study may be operating through another behavioral process, such as timing or time estimation, in addition to affecting delay sensitivity. For example, both haloperidol (Buhusi and Meck, 2002) and rimonabant (Han and Robinson, 2001) have been shown to affect timing in rodents by increasing overestimates of time. Although the current study was not designed to measure timing, the finding that both haloperidol and rimonabant increased discounting is consistent with the effects of these drugs on timing. That is, if delays to reinforcement were 'overestimated' after injections of haloperidol or rimonabant, one would expect decreases in behavior directed toward larger-later reinforcers.
Despite these alternative interpretations, the procedure used in the current study showed that haloperidol and rimonabant increased delay discounting in rats fed highfat and standard-chow diets. To our knowledge, this is the first study to find that haloperidol and rimonabant affect discounting in rats with different dietary histories. These findings provide support for the involvement of both the D2 and CB1 receptors in controlling delay discounting and emphasize the importance of understanding the effects of dietary history on behavioral responses to drugs that target the D2 and CB1 receptor.
